Imagine tiny robots acting like spiders to weave a complex web of blood vessels and cells. This web creates a living scaffold that mimics how our organs are built. By using these mini-robots, scientists can grow custom human tissue, like parts of the brain, to replace damaged organs without needing a donor.
Millions of patients die waiting for organ transplants because current tissue engineering cannot create complex vascular networks or blood-brain barriers.
A working spiderbot designed to create fibrillar tissue scaffolds and a microfluidic system to host a functioning blood-brain-barrier.
If you are a biotech startup dealing with the lack of donor organs — this project developed a robotic manufacturing technology that creates vascularized human tissues. This allows for patient-tailored organ repair, potentially removing the need for cadaveric donors.
If you are a drug discovery firm dealing with the difficulty of testing brain-targeted drugs — this project developed a functioning blood-brain-barrier (BBB) on a microfluidic system. This provides a more accurate in vitro model for testing how drugs enter the brain.
If you are a device manufacturer dealing with the inability to create complex blood vessel networks in 3D prints — this project developed spiderbots and self-assembling fibers. This technology enables micrometric precision in positioning cells and angiogenic factors.
Based on available project data, specific unit costs or pricing models for the tissue production are not provided.
The project envisions the use of pools of bioinspired mini-robots in fully automated production plants to establish a Tissue Engineering industry.
Based on available project data, there is no specific information regarding patents or licensing agreements.
The project data does not specify a production timeline, but it focuses on maintaining tissues alive for long periods for transportation to clinics.
The long-term vision is to produce personalized tissues in automated plants and transport them to hospitals and clinics.
The consortium is well-balanced for technology transfer, consisting of 6 partners across 4 countries. With a 50% industry ratio (3 industrial partners, including 2 SMEs), the project ensures that the robotic manufacturing techniques are developed with commercial scalability and industrial application in mind from the start.
Contact the Universidad Politecnica de Madrid
Contact us to explore licensing opportunities for the spiderbot technology.
